HAVCR2 and neoplasm: More recently, Chen et al. reported that TIM-3 functions as a pan-cellular immunosuppressive molecule that contributes to both T cell exhaustion and tumor-intrinsic resistance to immune checkpoint therapy (Chen et al., 2024).